Related Experiment Video
Updated: Sep 21, 2025

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
A bibliometric analysis for relapsed/refractory Non-Hodgkin lymphoma
1Department of Hematology, Yue Yang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. yongmingz666@163.com.
This bibliometric analysis identifies leading research teams and institutions in relapsed/refractory Non-Hodgkin lymphoma (r/r NHL). It highlights evolving research trends from traditional therapies to novel targeted drugs and evidence-based medicine (EBM) criteria.
Area of Science:
- Hematology
- Oncology
- Bibliometrics
Background:
- Relapsed/refractory Non-Hodgkin lymphoma (r/r NHL) presents significant treatment challenges.
- Understanding research dynamics is crucial for advancing therapeutic strategies.
Purpose of the Study:
- To analyze publication trends and identify key contributors in the field of r/r NHL.
- To map the research landscape and pinpoint emerging areas of interest.
Main Methods:
- Bibliometric analysis of 567 publications from 2009-2021.
- Utilized CiteSpace software for analyzing authors, institutions, countries, and keywords.
Main Results:
- Identified leading research teams (Zinzani, Tobinai, Goy, Vose) and the USA as a major contributor.
- Key research areas include mantle cell lymphoma, T-cell lymphoma, and novel targeted therapies.
- Research trends shifted from chemotherapy and transplantation to targeted drugs and EBM.
Conclusions:
- Provides insights into 12-year research hotspots and trends in r/r NHL.
- Offers valuable information for clinicians and researchers navigating complex data in the field.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Non-LTR Retrotransposons

